Overview

A Study Comparing Oxymetazoline 1% Cream to RHOFADE

Status:
Completed
Trial end date:
2019-05-31
Target enrollment:
Participant gender:
Summary
randomized, double-blind, placebo controlled
Phase:
Phase 1
Details
Lead Sponsor:
Taro Pharmaceuticals USA
Treatments:
Oxymetazoline
Phenylephrine